PRVA
Privia Health Group, Inc. · NASDAQ
- Sector Finance
- Industry Life/Health Insurance
- Website riviahealth.com
- Employees(FY) 964
- ISIN US74276R1023
Performance
-7.93%
1W
+16.6%
1M
+3.18%
3M
+23.02%
6M
-9.73%
YTD
-9.17%
1Y
Profile
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.
Technical Analysis of PRVA 2024-11-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-18 11:40
- 2024-11-14 06:52
- 2024-11-12 19:00
PRVA: Raising target price to $24.00(Argus Research)
- 2024-11-08 18:00
- 2024-11-08 11:24
- 2024-11-07 09:47
Privia Health Q3 Adjusted EPS, Revenue Increase(MT Newswires)
- 2024-11-07 09:30
- 2024-11-07 06:13
Privia Health: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-11-07 06:00
Privia Health Reports Third Quarter 2024 Financial Results(GlobeNewswire)
- 2024-11-06 18:15
Privia Health (PRVA) Misses Q3 Earnings Estimates(Yahoo Finance)
- 2024-11-06 17:00
Privia Health Reports Third Quarter 2024 Financial Results(Globenewswire)
- 2024-11-06 07:15
- 2024-11-05 19:00
PRVA: Raising target price to $20.00(Argus Research)
- 2024-11-05 10:00
- 2024-10-31 10:02
- 2024-10-29 17:04
- 2024-10-29 05:04
- 2024-10-15 05:57
- 2024-10-11 06:43
- 2024-10-09 17:31
- 2024-10-08 20:00
PRVA: What does Argus have to say about PRVA?(Argus Research)
- 2024-10-08 09:00
- 2024-10-07 21:00
- 2024-09-12 17:37
- 2024-08-27 20:00
PRVA: Raising target price to $22.00(Argus Research)
- 2024-08-20 20:00
PRVA: Raising target price to $21.00(Argus Research)
- 2024-08-16 06:47
- 2024-08-10 09:11
- 2024-08-08 09:30
- 2024-08-08 09:26
Page 1 of 7
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.